Gestational stress leads to depressive-like behavioural and immunological changes in the rat

NeuroImmunoModulation

Volumn 13, Issue 2, 2006, Pages 82-88

  O'Mahony, Siobhain M ^a,b,c   Myint, Aye Mu ^a   Van Den Hove, Daniel ^a   Desbonnet, Lieve ^a,b   Steinbusch, Harry ^a   Leonard, Brian E ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Blood and brain cytokines; Forced swim test; Postpartum depression

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BLOOD CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; FEMALE; FORCED SWIMMING TEST; HIPPOCAMPUS; HYPOTHALAMUS; IMMOBILIZATION; NONHUMAN; PREFRONTAL CORTEX; PREGNANCY; PRIORITY JOURNAL; PUERPERAL DEPRESSION; PUERPERIUM; RAT; RAT STRAIN; RISK ASSESSMENT; RISK FACTOR; STRESS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION, POSTPARTUM; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; RATS, INBRED F344; RESTRAINT, PHYSICAL; STRESS; SWIMMING; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33751307887     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096090     Document Type: Article

References (36)

1. Pop V, Essed GG, De Geus CA, van Son MM, Komproe IH: Prevalence of postpartum depression - or is it post-puerperium depression? Acta Obstet Gynecol Scand 1993;72:354-358.
2. Beck CT: The effects of postpartum depression on child development: a meta-analysis. Arch Psychiatr Nurs 1998;12:12-20.
3. Cogill G, Caplan HL, Alexandra H, Robson KM, Kumar R: Impact of postnatal depression on cognitive development of young children. Br Med J Clin Res 1986;292:1165-1167.
4. Richards JP: Post-natal depression: a review of recent literature. Br J Gen Pract 1990;40:472-476.
5. Steiner M, Tam W: Postpartum depression in relation to other psychiatric disorders; in Miller J (ed): Postpartum Mood Disorders. Washington, American Psychological Press, 1999, pp 47-63.
6. O'Hara M, Schlechte J, Lewis D, Varner M: Controlled prospective study of postpartum mood disorders. J Abnorm Psychol 1991;100:63-73.
7. Saisto J, Salmela-Aro K, Nurmi J, Halmesmaki E: Psychosocial predictors of disappointment with delivery and puerperal depression. Acta Obstet Gynecol Scand 2001;80:39-45.
8. Galea LAM, Wide JK, Barr AM: Estradiol alleviates depressive-like symptoms in a novel animal model of postpartum depression. Behav Brain Res 2001;122:1-9.
9. Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpé S: Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon that is related to immune activation. Life Sci 2002;71:1837-1848.
10. Cizza G, Gold PN, Chrousos GP: High dose transdermal estrogen, corticotrophin releasing hormone and postnatal depression. J Clin Endocrinol Metabol 1997;82:703-704.
11. Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpé S: Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and postpartum anxiety and depression. Psychol Med 2001;31:847-858.
12. Faas MM, Moes H, van der Schaaf G, de Liij LFMH, Heineman MJ: Total white blood cell counts and LPS-induced TNF-α production by monocytes of pregnant, pseudopregnant and cyclic rats. J Reprod Immunol 2003;59:39-52.
13. MacLean MA, Wilson R, Thomson JA, Krishnamurthy S, Walker J: Immunological changes during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1992;43:167-172.
14. Hagen P, Poole S, Briston AF: Immunosuppressive activity of corticotrophin releasing factor. Inhibition of interleukin-1 and interleukin-6 production by human mononuclear cells. Biochem J 1992;281:251-254.
15. Sacks GP, Sargent I, Redman C: An innate view of human pregnancy. Immunol Today 1999;20:114-118.
16. Rebelo I, Carvalho-Guerra F, Pereira-Leita L, Quintanilha A: Comparative study of lactoferrin and other blood markers of inflammation stress between preeclamptic and normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;64:167-173.
17. Maes M, Smith R: Immune activation and major depression: a hypothesis; Psychiatry, Current Medical Literature. London, The Royal Society of Medicine, 1997.
18. Heyes MP, Saito S, Markey SP: Human macrophages convert L -tryptophan into the neurotoxin quinolinic acid. Biochem J 1992;283:633-635.
19. Mellor AL, Munn DH: Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 1999;20:469-473.
20. Sher L: Daily hassles, cortisol and the pathogenesis of depression. Med Hypotheses 2004;62:198-202.
21. Morask A, Maier SF, Watkins LR, Fleshner M: Elevated interleukin-1β contributes to antibody suppression produced by stress. J Appl Physiol 2002;93:207-215.
22. LeMay LG, Vander AJ, Kluger MJ: The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav 1990;47:957-961.
23. Smith JW, Sukl JR, Evans AJ, Costall B, Smythe JW: Gestational stress induces postpartum depressive-like behaviour and alters maternal care in rats. Psychoneuroendocrinology 2004;29:227-244.
24. Van den Hove DL, Blanco CE, Aendekerk B, Desbonnet L, Bruschettini M, Steinbusch HP, Prickaerts J, Steinbusch HW: Prenatal stress and long-term affective consequences. Dev Neurosci 2005;27:313-320.
25. Porsolt RD, Lenegre A, McArthur RA: Pharmacological models of depression; in Olivier B, Mos J, Slangen JL (eds): Animal Models in Psychopharmacology. Berlin, Birkhäuser, 1991, pp 137-160.
26. Lowry O, Rosebrough W, Farr A, Randall R: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
27. Llewelyn AM, Stowe ZN, Nemeroff CB: Depression during pregnancy and the puerperium. J Clin Psychol 1997;58(suppl 15):26-32.
28. Burt VK, Stein K: Epidemiology of depression throughout the female life cycle. J Clin Psychol 2002;63(suppl 7):9-15.
29. Frye CA, Walf A: Hippocampal 3α, 5α-THP may alter depressive behaviour of pregnant and lactating rats. Pharmacol Biochem Behav 2004;78:531-540.
30. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HJ, Kling MJ, Chrousos GP, Gold PW: Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005;90:2522-2530.
31. Song C, Leonard BE: The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 2005;29:627-647.
32. Elenkov IJ, Chrousos GP: Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002;966:290-303.
33. Turnbull AV, Rivier CL: Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999;79:1-71.
34. Black PH: Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 2002;16:622-653.
35. Maes M, Libbrecht I, Lin A, Goossens F, Ombelet WU, Vanderput MJ, Bosmans E, Altamura C, Cox J, DeJongh R, Scharpé S: Immune activation in early puerperium is related to postpartum affective symptoms. Psychoneuroendocrinology 2000;25:121-137.
36. Maier SF: Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav Immun 2003;17:69-85.